IRADIMED CORPORATION Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent
IRADIMED CORPORATION (IRMD) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent of -1.30% for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-06.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost · last filed 2026-03-06
- IRADIMED CORPORATION effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, percent for the quarter ending 2017-03-31 was 8.40%, a 740.00% increase year-over-year.
- IRADIMED CORPORATION effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, percent for the quarter ending 2016-03-31 was 1.00%.
- IRADIMED CORPORATION effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, percent for fiscal 2025 was -1.30%.
- IRADIMED CORPORATION effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, percent for fiscal 2024 was -1.00%.
- IRADIMED CORPORATION effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, percent for fiscal 2023 was -0.90%.
- IRADIMED CORPORATION effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, percent for fiscal 2022 was -0.70%.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent 3 month | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent 12 month | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent 12 month as first filed |
|---|---|---|---|
| 2025-12-31 | -1.30% 10-K · filed 2026-03-06 | ||
| 2024-12-31 | -1.00% 10-K · filed 2026-03-06 | ||
| 2023-12-31 | -0.90% 10-K · filed 2026-03-06 | ||
| 2022-12-31 | -0.70% 10-K · filed 2024-03-01 | ||
| 2021-12-31 | -15.20% 10-K · filed 2023-03-02 | ||
| 2020-12-31 | 197.10% 10-K · filed 2022-03-04 | ||
| 2019-12-31 | -9.80% 10-K · filed 2022-03-04 | ||
| 2018-12-31 | -0.20% 10-K · filed 2021-03-05 | ||
| 2017-12-31 | 5.30% 10-K · filed 2020-03-06 | ||
| 2017-03-31 | 8.40% 10-Q · filed 2017-05-05 | ||
| 2016-12-31 | -0.80% 10-K · filed 2019-03-07 | -0.30% 10-K · filed 2017-03-10 | |
| 2016-03-31 | 1.00% 10-Q · filed 2017-05-05 | ||
| 2015-12-31 | 2.90% 10-K · filed 2018-03-08 | ||
| 2014-12-31 | 0.30% 10-K · filed 2017-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |